ArticleScientific reports2025
Colorless and transparent polyimide nanocomposite films containing organically modified fillers comprising an organoclay/functionalized-graphene complex.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Aromatic colorless and transparent polyimides (CPIs) are super engineering polymers with excellent mechanical performance and thermal stability, making them particularly suitable for optical displays and electronic materials. In this study, a complex filler was dispersed into poly(amic acid) (PAA) synthesized from dianhydride 5,5'-sulfonylbis(isobenzo-furan-1,3-dione) and diamine bis[4-(3-aminophenoxy) phenyl]sulfone monomers using a solution intercalation method, resulting in the formation of a PAA hybrid. Solutions of this PAA hybrid were thermally imidized through various heat treatments to synthesize CPI hybrid films. A new complex filler containing both clay and graphene was synthesized through organic surface modification of the clay and graphene, and the synergistic effects of the two fillers were investigated. A C16-complex synthesized from an organoclay (hexadecyl-montmorillonite, C16-MMT) and functionalized graphene sheets (hexadecyl-graphene sheet, C16-GS) was used as the complex filler in this study. CPI hybrid films were fabricated by dispersing various loading (0-2.0 wt%) of the C16-complex filler into a CPI matrix, and their thermomechanical properties, filler dispersion morphology, and optical transparency were analyzed based on their filler content. In the CPI hybrid films, the C16-complex exhibited excellent nanoscale dispersion at a filler content of 1.0 wt%, and the corresponding systems showed excellent thermomechanical properties; however, when the filler content exceeded the critical content, filler aggregation occurred, adversely affecting the properties of the hybrid films. In contrast, the optical properties of the hybrid films gradually deteriorated with increasing filler content.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.